Navigation Links
Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies
Date:3/7/2012

ption medicines, vitamins, and herbal supplements.

What are the possible side effects of TRADJENTA?

The most common side effects of TRADJENTA include stuffy or runny nose and sore throat.

You are encouraged to report negative side effects of prescription drugs to the FDA.  Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more safety information, please see Patient Information and full Prescribing Information.

To learn more about TRADJENTA visit: www.TRADJENTA.com.  For full prescribing information visit: http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Tradjenta/Tradjenta.pdf or call Boehringer Ingelheim Pharmaceuticals, Inc. at 1-800-542-6257

Please report any unexpected effects or product problems to the Boehringer Ingelheim Drug Information Unit by calling 1-800-542-6257.

Boehringer Ingelheim and Eli Lilly and Company
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in the field of diabetes that centers on four pipeline compounds representing several of the largest treatment classes. This alliance leverages the companies' strengths as two of the world's leading pharmaceutical companies, combining Boehringer Ingelheim's solid track record of research-driven innovation and Lilly's innovative research, experience, and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the alliance at www.boehringer-ingelheim.com or '/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  Janssen Research & Development, ... Drug Administration (FDA) has accepted for Priority Review ... a treatment for patients with multiple myeloma who ... and an immunomodulatory agent (IMiD), or who have ... including a PI and an IMiD. This is ...
(Date:9/4/2015)... Sept. 4, 2015  Pharmaceutical companies today rely ... Field-Based Medical Specialists (FBMS) to build and strengthen ... thought leaders in critical therapeutic areas. ... teams, companies are expanding the critical MSL function ... with corporate objectives and to achieve regional consistency, ...
(Date:9/4/2015)... Today, the Centers for Disease Control and Prevention (CDC) ... for States , a new program to help states ... Prevention for States program, as part of the ... will make a strong investment in 16 states, giving ... prevent overdose deaths related to prescription opioids. The program ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2CDC funding helps states combat prescription drug overdose epidemic 2CDC funding helps states combat prescription drug overdose epidemic 3
... Ranbaxy Laboratories Inc. (RLI), a wholly owned subsidiary of ... U.S. Food and Drug Administration (FDA) has approved Absorica™, ... isotretinoin, for the treatment of severe recalcitrant nodular acne. ... Pharmaceuticals Inc., RLI is expected to launch Absorica™ in ...
... May 29, 2012 Oramed Pharmaceuticals Inc. ... drug delivery systems, announced today that it has received ... Patent Office. The patent, entitled "Methods and Compositions for ... using the company,s technology. Oramed,s portfolio now consists of ...
Cached Medicine Technology:Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA 2Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand 2Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand 3
(Date:9/4/2015)... , ... September 04, 2015 , ... ... the surrounding communities, is launching a charity effort to provide for the family ... to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County ... Core Compassion Project is a non-profit organization dedicated to offering Pilates scholarships ... of cancer treatments and recover their mobility, strength, and range of motion following ...
(Date:9/4/2015)... ... September 04, 2015 , ... San ... available at CitiDent. CEREC is a newer method for creating restorations through innovative ... patients by eliminating the need for multiple appointments, CEREC produces restorations with total ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way ... , The patent-pending K Med Cups provide a quick and simple way to brew a ... cold, flu or cough. As a result, they enhance comfort and health. The invention features ...
(Date:9/4/2015)... Portland, ME (PRWEB) , ... September 04, 2015 ... ... Symposium focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 ... ihsymposium.com/focus-event. , Speakers at the 2015 symposium are doctors and researchers at the ...
Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... As Both a Membership Card and Debit Card for Health-related ... and inconvenience often associated with a Flexible Spending Account (FSA) ... This card - which is unique to Western Pennsylvania - ... as a debit card for out-of-pocket health care expenses.The ...
... laughing gas may be enhanced by suggestion or ... College London). The study,s findings that people are ... patients may benefit from being coached to relax while ... used by dentists to sedate their patients before treatment, ...
... Nationally With More than 1,800 in Florida Alone ST. ... medical identification franchise, announced today the launch of its ... device to consumers containing their comprehensive medical history. ... their private medical history on an easy-to-carry or wearable ...
... Financial Group is pleased to announce that James D. Hohman, ... as one of the "150 Best Financial Advisors for Doctors ... is one of only six advisors from Pennsylvania included in ... , , Candidates were selected to the list ...
... even today,s) health problems may be found among the ... ShowLAS VEGAS, Jan. 9 /PRNewswire-USNewswire/ -- ... way we shop, listen to music, and even stay ... an illness or disability remains a frightening, stressful, and ...
... says the drugs should only be used short-term, ... News) -- Alzheimer,s patients who are prescribed antipsychotic ... similar patients not given these medications do, British ... antipsychotics has been found to benefit Alzheimer,s patients, ...
Cached Medicine News:Health News:UPMC Health Plan Introduces `MyFlex Advantage' Card 2Health News:UPMC Health Plan Introduces `MyFlex Advantage' Card 3Health News:People are more suggestible under laughing gas 2Health News:People are more suggestible under laughing gas 3Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 2Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 3Health News:Meridian Makes CES Good For Your Health 2Health News:Antipsychotics Up Death Risk in Alzheimer's Patients 2Health News:Antipsychotics Up Death Risk in Alzheimer's Patients 3
Microforceps: Diamond Dusted Micro Pic Forceps...
Ultra-fine pointed forceps with diamond dusting on inner tip surface for enhanced grasping of tissue. Ideal for fine membrane grasping....
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Pic forceps design that is slightly curved; tips have special "surface treatment" for enhanced manipulation of the retina....
Medicine Products: